Skip to main content

Table 3 Frequency of priority selection and agreement level for funding scenarios (N = 1631)

From: Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey

Priority Selection
Description Frequency (%)
Improve Quality of Life 1304 (80.0)
Effective Health Care 1232 (75.5)
National Equal Access 701 (43.0)
Pain Reduction 642 (39.4)
Cost Containment 543 (33.3)
Severity of Symptoms 430 (26.4)
Longer Life 376 (23.1)
Lack of Current Treatment 372 (22.8)
Funding Scenario by Agreement Level
Description Agreement Level Frequency (%)
Canadawide Equality Agree 1292 (79.2)
Neither agree nor disagree 229 (14.0)
Disagree 95 (5.8)
No response 15 (0.9)
Fund Drug if Justified Agree 1190 (73.0)
Neither agree nor disagree 311 (19.1)
Disagree 115 (7.1)
No response 15 (0.9)
Pay for Drugs Agree 818 (50.2)
Neither agree nor disagree 484 (29.7)
Disagree 305 (18.7)
No response 24 (1.4)
Prioritize Other Programs Agree 601 (36.8)
Neither agree nor disagree 549 (33.7
Disagree 460 (28.2)
No response 21 (1.3)
  1. Agree: 4 = agree and 5 = completely agree; Disagree: 1 = completely disagree and 2 = disagree; Neither agree nor disagree: 3 = neutral